Swedish News, In a Phase 1/2 open-label trial out of a collaboration between Lund and Cambridge universities, and conducted in Skåne University Hospital. Researchers evaluated the therapeutic potential of transplanting laboratory-produced dopaminergic progenitor cells into the brains of Parkinson’s patients. Earlier approaches relied on fetal tissue donations, which face significant supply constraints. The progenitor cells…

Read more →